334
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Recurrent urinary tract infections in non-pregnant adult women

, MMed (OetG), FCOG
Pages 467-470 | Received 02 Aug 2009, Accepted 15 Sep 2009, Published online: 15 Aug 2014

References

  • Rahn DD. Urinary tract infections: contemporary management. Urol Nurs 2008; 28(5): 333–341.
  • Foxman B, Barlow R, D'Arcy H, et al. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 2000; 10: 509–15.
  • Johnson JR, Stamm WE. Diagnosis and treatment of acute urinary tract infections. Infect Dis Clin North Am 1987; 1(4): 773–791.
  • Hooton TM, Scholes D, Hughes JP, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996; 335: 468–474.
  • Foxman B, Gillespie B, Koopman J, et al. Risk factors for second urinary tract infection among college women. Am J Epidemiol 2000; 151: 1194–205.
  • Jackson SL, Boyko EJ, Scholes D, et al. Predictors of urinary tract infection after menopause: a prospective study. Am J Med 2004; 117: 903–911.
  • Fihn SD. Acute uncomplicated urinary tract infection in women. N Engl J Med 2003; 349: 259–66.
  • Ferry SA, Holm LSE, Stenlund H, et al. The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized controlled study. Scand J Infect Dis 2004; 36: 296–301.
  • Nickel JC, Lee JC, Grantmyre JE, et al. Natural history of urinary tract infection in a primary care environment in Canada. Can J Urol 2005; 12: 2718–37.
  • Scholes D, Hooton TM, Roberts PL, et al. Risk factors for recurrent urinary tract infection in young women. J Infect Dis 2000; 182: 1177–82.
  • Ikaheimo R, Siitonen A, Heiskanen T, et al. Recurrence of urinary tract infection in a primary care setting: analysis of a one-year follow-up of 179 women. Clin Infect Dis 1996; 22: 91–9.
  • Dwyer PL, O'Reilly M. Recurrent urinary tract infection in the female. Curr Opin Obstet Gynecol 2002; 14: 537–543.
  • Russo TA, Stapleton A, Wenderoth S, et al. Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women. J Infect Dis 1995; 172: 440–445.
  • Hill JE, Goh SH, Money DM, et al. Characterization of vaginal microflora of healthy, nonpregnant women by chaperonin-60 sequence-based methods. Am J Obstet Gynecol. 2005; 193: 682–692
  • Larsen B, Monif GR. Understanding the bacterial flora of the female genital tract. Clin Infect Dis 2001; 32: e69–7e7.
  • Czaja CA, Stamm WE, Stapleton AE, et al. Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women. J Infect Dis 2009 Jul 8. [Epub ahead of print]
  • Raz R, Gennesin Y, Wasser J, et al. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis 2000; 30: 152–6.
  • Hu KK, Boyko EJ, Scholes D, et al. Risk factors for urinary tract infections in postmenopausal women. Arch Intern Med 2004; 164: 989–93.
  • Hooton TM, Besser R, Foxman B, et al. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis 2004; 39: 75–80.
  • Griebling TL. Urologic diseases in America project: trends in resource use for urinary tract infections in women. J Urol 2005; 173: 1281–1287.
  • Hopkins WJ, Uehling DT, Wargowski DS. Evaluation of a familial predisposition to recurrent urinary tract infections in women. Am. J. Med. Genet 1999; 83: 422–424.
  • Wullt B, Bergsten G, Fischer H, et al. The host response to urinary tract infection. Infect Dis Clin North Am 2003; 17: 279–301.
  • Suman E, Gopalkrishna Bhat K, Hegde BM. Bacterial adherence and immune response in recurrent urinary tract infection. Int J Gynaecol Obstet 2001; 75: 263–268.
  • Kirjavainen PV, Pautler S, Baroja ML, Anukam K, Crowley K, Carter K, Reid G. Abnormal immunological profile and vaginal microbiota in women prone to urinary tract infections. Clin Vacc Immunol 2009; 16(1): 29–36.
  • Finer G, Landau D. Pathogenesis of urinary tract infections with normal female anatomy. Lancet Infect Dis 2004; 4: 631–635.
  • Wegenlehner FME, Naber KG. Uncomplicated urinary tract infections in women. Curr Opin Urol 2001; 11: 49–53.
  • Bent S, Nallamothu BK, Simel DL, et al. Does this woman have an acute uncomplicated urinary tract infection? JAMA 2002; 287: 2701–2710.
  • Gupta K, Hooton TM, Roberts PL, et al. Patient initiated treatment of uncomplicated recurrent urinary tract infections in young women. Ann Intern Med 2001; 135: 9–16.
  • Barry HC, Hickner J, Ebell MH, et al. A randomized, controlled trial of telephone management of suspected urinary tract infections in women. J Fam Pract 2001; 50: 589–594.
  • Saint S, Scholes D, Fihn SD, et al. The effectiveness of a clinical practice guideline for the management of presumed uncomplicated urinary tract infection in women. Am J Med 1999; 106: 636–641.
  • Aagaard EM, Nadler P, Adler J, et al. An interactive computer kiosk module for the treatment of recurrent uncomplicated cystitis in women. J Gen Intern Med 2006; 21: 1156–1159.
  • Gupta K, Sahm DF, Mayfield D, et al. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis 2001; 33: 88–94.
  • Gupta K. Addressing antibiotic resistance. Am J Med 2002; 113(1A): 29S–34S.
  • Zhanel GG, Hisanaga TL, Laing NM, et al. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 2005; 26(5): 380–388.
  • Naber KG, Schito GC, Gualco L (on behalf of the ARESC working group). An international survey on etiology and susceptibility of uropathogens isolated from women with uncomplicated UTI: the ARESC study. In: Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Chicago, IL, 2007.
  • Milo G, Katchman E, Paul M, Christiaens T, Baerheim A, Leibovici L. Duration of antibacterial treatment for uncomplicated urinary tract infection in women. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD004682. DOI: 10.1002/14651858.CD004682.pub2.
  • Leibovici L, Wysenbeek AJ. Single-dose antibiotic treatment for symptomatic urinary tract infections in women: a meta-analysis of randomized trials. Q J Med 1991; 78: 43–57.
  • Schito GC. Why fosfomycin trometamol as first line therapy for uncomplicated UTI? Int J Antimicrob Agents 2003 Oct; 22 Suppl 2: 79–83.
  • Nicolle LE, Madsen KS, Debeeck GD, et al. Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women. Scand J Infect Dis 2002; 34: 487–492.
  • Albert X, Huertas I, Pereiro I, Sanfélix J, Gosalbes V, Perrotta C. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD001209. DOI: 10.1002/14651858.CD001209.pub2.
  • Schooff M, Hill K. Antibiotics for recurrent urinary tract infections. Am Fam Physician 2005; 71(7): 1301–1302.
  • Stothers L. A randomized trial to evaluate effectiveness and cost-effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection. Can J Urol 2002; 9: 1558–1562.
  • Jepson RG, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD001321. DOI: 10.1002/14651858.CD001321.pub4.
  • Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD005131. DOI: 10.1002/14651858.CD005131.pub2.
  • L Kwok L, Stapleton AE, Stamm WE, Hillier SL, Wobbe CL, Gupta K. Adherence of Lactobacillus crispatus to vaginal epithelial cells from women with or without a history of recurrent urinary tract infection. J Urology 2006; 176: 2050–2054.
  • Reid G, Bruce AW. Probiotics to prevent urinary tract infections: the rationale and evidence. World J Urol 2006; 24: 28–32.
  • Abad CL, Safdar N. The role of lactobacillus probiotics in the treatment or prevention of urogenital infections—a systematic review. J Chemother 2009; 21(3): 243–252.
  • Naber KG, Cho YH, Matsumoto T, Schaeffer AJ. Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int J Antimicrob Agents 2009; 33(2): 111–119.
  • Hopkins WJ, Uehling DT. Vaccine development for the prevention of urinary tract infections. Curr Infect Dis Rep 2002; 4: 509.
  • Hopkins WJ, Elkahwaji J, Beierle LM, Leverson GE, Uehling DT. Vaginal mucosal vaccine for recurrent urinary tract infections in women: Results of a phase 2 clinical trial. J Urol 2007; 177: 1349–1353.
  • Albrecht U, Goos KH, Schneider B. A randomised, double-blind, placebo-controlled trial of a herbal medicinal product containing Tropaeoli majoris herba (Nasturtium) and Armoraciae rusticanae radix (Horseradish) for the prophylactic treatment of patients with chronically recurrent lower urinary tract infections. Curr Med Res Opin 2007; 23(10): 2415–22.
  • Heyns CF, Fisher M. The urological management of the patient with acquired immunodeficiency syndrome. B J U Int 2005; 9 5: 709–716.
  • Steele BW, Carson CC. Recognizing the urologic manifestations of HIV and AIDS. Contemp Urol 1997; 9: 39–53.
  • Hyun G, Lowe FC. AIDS and the urologist. Urol Clin N Am 2003; 30: 101–109.
  • O'Regan S, Russo P, Lapointe N, Rousseau E. AIDS and the urinary tract. J Acquir Immune Defic Syndr 1990; 3: 244–251.
  • Kaplan MS, Wechsler M, Benson MC. Urologic manifestations of AIDS. Urology 1987; 30: 441–443.